Efficacy and Safety of AR882, a Selective Uric Acid Transporter 1 (URAT1) Inhibitor, in Gout Patients with Various Baseline Characteristics Following 12-Week Treatment in Patients

AR882 - Arthrosi

https://acr23.eventscribe.net/fsPopup.asp?PresentationID=1324649&mode=presInfo

James Cheng-Chung Wei1; Roy Fleischmann2; sarah Morris3; Vijay Hingorani4; Elizabeth Polvent5; Zancong Shen6; Shunqi Yan7; Li-Tain Yeh8; Robert Keenan9

Sep 24, 2023